These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7702316)

  • 21. A survival benefit from radical prostatectomy for early prostate cancer.
    Ray E; O'Brien T
    Int J Clin Pract; 2005 Oct; 59(10):1122-3. PubMed ID: 16178975
    [No Abstract]   [Full Text] [Related]  

  • 22. [Adenocarcinoma of the prostate].
    Dvorácek J
    Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
    Malaeb BS; Rashid HH; Lotan Y; Khoddami SM; Shariat SF; Sagalowsky AI; McConnell JD; Roehrborn CG; Koeneman KS
    Urol Oncol; 2007; 25(4):291-7. PubMed ID: 17628294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radical prostatectomy.
    Hammad FT
    Ann N Y Acad Sci; 2008 Sep; 1138():267-77. PubMed ID: 18837906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chances and risks of prevention in elderly people for the three major cancers: breast-, prostate- and colorectal cancers].
    Kolb GF
    Zentralbl Gynakol; 2006 Jun; 128(3):123-8. PubMed ID: 16758377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of high-grade prostatic intraepithelial neoplasia in prostate gland of Korean men: comparisons between radical prostatectomy and cystoprostatectomy.
    Han KS; Jeong IG; Joung JY; Yang SO; Chung J; Seo HK; Park WS; Lee KH
    Urology; 2007 Dec; 70(6):1100-3. PubMed ID: 18158026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radical prostatectomy versus watchful waiting in early prostate cancer.
    Kirkpatrick J
    J Insur Med; 2002; 34(2):131-2. PubMed ID: 15305791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does initial surveillance in early prostate cancer reduce the chance of cure by radical prostatectomy?--A case control study.
    Khatami A; Damber JE; Lodding P; Pihl CG; Hugosson J
    Scand J Urol Nephrol; 2003; 37(3):213-7. PubMed ID: 12775279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
    Zincke H; Lau W; Bergstralh E; Blute ML
    J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surgical and medical treatment for localized prostate cancer].
    Kawai K
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):1002-5. PubMed ID: 17637535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy.
    Nam RK; Jewett MA; Krahn MD; Robinette MA; Tsihlias J; Toi A; Ho M; Evans A; Sweet J; Trachtenberg J
    Can J Urol; 2003 Jun; 10(3):1891-8. PubMed ID: 12892576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results.
    Roehl KA; Eggener SE; Loeb S; Smith ND; Antenor JA; Catalona WJ
    Urol Oncol; 2006; 24(6):465-71. PubMed ID: 17138126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target populations and strategies for chemoprevention trials of prostate cancer.
    Bostwick DG
    J Cell Biochem Suppl; 1994; 19():191-6. PubMed ID: 7823591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited.
    Vaidya A; Soloway MS
    J Urol; 2000 Dec; 164(6):1998-2001. PubMed ID: 11061900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Men's experiences following laparoscopic radical prostatectomy: a qualitative descriptive study.
    Milne JL; Spiers JA; Moore KN
    Int J Nurs Stud; 2008 May; 45(5):765-74. PubMed ID: 17482192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percentage of free serum prostate-specific antigen as a predictor of pathologic features of prostate cancer in a screening population.
    Arcangeli CG; Humphrey PA; Smith DS; Harmon TJ; Shepherd DL; Keetch DW; Catalona WJ
    Urology; 1998 Apr; 51(4):558-64; discussion 564-5. PubMed ID: 9586607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathological features after radical prostatectomy in potential candidates for active monitoring.
    Griffin CR; Yu X; Loeb S; Desireddi VN; Han M; Graif T; Catalona WJ
    J Urol; 2007 Sep; 178(3 Pt 1):860-3; discussion 863. PubMed ID: 17631347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The surgical learning curve for prostate cancer control after radical prostatectomy.
    Vickers AJ; Bianco FJ; Serio AM; Eastham JA; Schrag D; Klein EA; Reuther AM; Kattan MW; Pontes JE; Scardino PT
    J Natl Cancer Inst; 2007 Aug; 99(15):1171-7. PubMed ID: 17652279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial.
    Wallace K; Fleshner N; Jewett M; Basiuk J; Crook J
    J Clin Oncol; 2006 Sep; 24(25):4158-62. PubMed ID: 16943531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A fair trial? The European randomized prostatic cancer study].
    Scholten HJ
    Ned Tijdschr Geneeskd; 1995 Jun; 139(25):1302-3. PubMed ID: 7541896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.